FindTrial
Sign In

A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19)

A Retrospective Study for Preventive Medication in Tongji Hospital During the Epidemic of Novel Coronavirus Pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029728
Enrollment
Unknown
Registered
2020-02-10
Start date
2020-02-15
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Tongji Hospital affiliated to Tongji medical college of HUST
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Staff of tongji hospital willing to participate this study; 2. Aged >=18 years.

Exclusion criteria

Exclusion criteria: 1. Meets any contraindications of ARB; 2. Meets any contraindications of Jinyebaidu Granule; 3. Pregnant women, lactating women, severe renal insufficiency.

Design outcomes

Primary

MeasureTime frame
The proportion of patients diagnosed with 2019-ncov viral pneumonia;—

Secondary

MeasureTime frame
Safety evaluation;—

Countries

China

Contacts

Public ContactLiu Dong

Tongji Hospital affiliated to Tongji Medical College of HUST

ld_2069@163.com+86 13507183749

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026